| Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence (NCT03197155) | Hospices Civils de Lyon | 2016-06-01 |
| Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection (NCT02867280) | Sun Yat-sen University | 2016-06-01 |
| Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC (NCT04722120) | Seoul National University Hospital | 2016-06-01 |
| Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224) (NCT02702414) | Merck Sharp & Dohme LLC | 2016-05-31 |
| Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240) (NCT02702401) | Merck Sharp & Dohme LLC | 2016-05-26 |
| Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma (NCT03267641) | National Cancer Centre, Singapore | 2016-05-16 |
| Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma (NCT02658019) | Lynn Feun, MD | 2016-05-06 |
| A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure (NCT02772029) | The First Affiliated Hospital of Zhengzhou University | 2016-05-01 |
| Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC (NCT03047603) | Eastern Hepatobiliary Surgery Hospital | 2016-05-01 |
| Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC (NCT02774187) | Sun Yat-sen University | 2016-05-01 |
| Surefire Precision Infusion System Registry (NCT02967523) | Surefire Medical, Inc. | 2016-05-01 |
| The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study (NCT05121571) | Sun Yat-sen University | 2016-04-21 |
| Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer (NCT02595866) | National Cancer Institute (NCI) | 2016-04-04 |
| By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy (NCT02725996) | Southwest Hospital, China | 2016-04-01 |
| LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma (NCT02524119) | University of Texas Southwestern Medical Center | 2016-04-01 |
| Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC) (NCT03156582) | University Hospital, Grenoble | 2016-04-01 |
| LifePearl-Doxo Pharmacokinetic (PK) Study (NCT02548780) | Terumo Europe N.V. | 2016-04-01 |
| Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma (NCT02748304) | Fudan University | 2016-04-01 |
| Contrast-enhanced Ultrasound Evaluation of Chemoembolization (NCT02764801) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2016-04-01 |
| Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients (NCT02523053) | Eastern Hepatobiliary Surgery Hospital | 2016-04-01 |
| Expanding Phase III Study of Tyroserleutide for Injection (NCT03516448) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2016-03-24 |
| First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer (NCT02716012) | Mina Alpha Limited | 2016-03-01 |
| Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma (NCT02730611) | Assistance Publique - Hôpitaux de Paris | 2016-03-01 |
| Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) (NCT02702960) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-01 |
| TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma (NCT02704130) | Wake Forest University Health Sciences | 2016-03-01 |
| Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study (NCT02702323) | Zhejiang Cancer Hospital | 2016-03-01 |
| Resection+Highly Purified CTL Versus Resection Alone for HCC (NCT02709070) | Sun Yat-sen University | 2016-03-01 |
| Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC (NCT02771405) | National Hepatology & Tropical Medicine Research Institute | 2016-03-01 |
| A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies (NCT02572687) | Eli Lilly and Company | 2016-02-19 |
| Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function (NCT02626312) | M.D. Anderson Cancer Center | 2016-02-15 |
| Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib (NCT02786342) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2016-02-15 |
| Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 (NCT02509507) | Amgen | 2016-02-05 |
| Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors (NCT02705105) | Kyowa Kirin, Inc. | 2016-02-01 |
| RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC (NCT02678013) | Ming Kuang | 2016-02-01 |
| Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment (NCT02745600) | University of Leipzig | 2016-02-01 |
| The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction (NCT03212625) | Korea University Guro Hospital | 2016-01-28 |
| A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma (NCT02460835) | University of Michigan Rogel Cancer Center | 2016-01-26 |
| Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction (NCT02649712) | Xuzhou Central Hospital | 2016-01-20 |
| Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma (NCT02868255) | Nantes University Hospital | 2016-01-03 |
| Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC (NCT02472249) | University Health Network, Toronto | 2016-01-01 |
| No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma (NCT02830737) | Southwest Hospital, China | 2016-01-01 |
| Effects of Antiviral Therapy on Patients With HBV-related HCC (NCT05406089) | First Affiliated Hospital Xi'an Jiaotong University | 2016-01-01 |
| Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma (NCT02729506) | King Faisal Specialist Hospital & Research Center | 2016-01-01 |
| Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis (NCT02309788) | Guangxi Medical University | 2016-01-01 |
| The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial. (NCT03368651) | Sun Yat-sen University | 2016-01-01 |
| Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases (NCT02511522) | Canadian Cancer Trials Group | 2015-12-11 |
| An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma (NCT02576509) | Bristol-Myers Squibb | 2015-12-07 |
| Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma (NCT02616926) | First Affiliated Hospital, Sun Yat-Sen University | 2015-12-01 |
| Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma (NCT02705118) | JOON-IL CHOI | 2015-12-01 |
| Metformin Plus Sorafenib for Advanced HCC (NCT02672488) | Tianjin Medical University Cancer Institute and Hospital | 2015-12-01 |
| Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients (NCT02642913) | Memorial Sloan Kettering Cancer Center | 2015-12-01 |
| Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients (NCT03113604) | Centre Hospitalier Universitaire, Amiens | 2015-11-20 |
| Gut Microbiota in People With Hepatocellular Carcinoma (HCC) (NCT02599909) | National Cancer Institute (NCI) | 2015-11-06 |
| The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma (NCT01953406) | Seoul National University Hospital | 2015-11-01 |
| Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications (NCT02936856) | Guangxi Medical University | 2015-11-01 |
| A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma (NCT02460991) | Boston Scientific Corporation | 2015-11-01 |
| Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor (NCT02562963) | Minghui Zhang | 2015-11-01 |
| A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma (NCT02519348) | MedImmune LLC | 2015-10-19 |
| Liver Fibrosis in Zambian HIV-HBV Co-infected Patients (NCT02344680) | University of Alabama at Birmingham | 2015-10-01 |
| HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B (NCT03048123) | Sun Yat-sen University | 2015-10-01 |
| The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib (NCT02564666) | Asan Medical Center | 2015-10-01 |
| A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients (NCT02727309) | Peking University Cancer Hospital & Institute | 2015-10-01 |
| Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor (NCT02587689) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2015-10-01 |
| Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System (NCT02525952) | Eastern Hepatobiliary Surgery Hospital | 2015-10-01 |
| Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma (NCT02585479) | Guangxi Medical University | 2015-10-01 |
| Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma (NCT02584556) | Guangxi Medical University | 2015-10-01 |
| Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma (NCT02534337) | Guangxi Medical University | 2015-09-01 |
| Hepatocellular Carcinoma Recurrence and Anesthesia (NCT02643173) | Seoul National University Bundang Hospital | 2015-09-01 |
| 11C-acetate for Treatment Response After Radiotherapy for HCC (NCT02549755) | Justin Sims | 2015-09-01 |
| Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma (NCT02525380) | Seoul National University Hospital | 2015-09-01 |
| Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma (NCT02527772) | Guangxi Medical University | 2015-09-01 |
| CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation (NCT04844112) | Seoul National University Hospital | 2015-08-01 |
| Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma (NCT02504983) | Chang Gung Memorial Hospital | 2015-08-01 |
| The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma (NCT02525965) | Eastern Hepatobiliary Surgery Hospital | 2015-08-01 |
| DEB-TACE for Hepatocellular Carcinoma (NCT02748161) | Surefire Medical, Inc. | 2015-08-01 |
| Metabolic Signature of Healthy Lifestyle and HCC (NCT03356535) | International Agency for Research on Cancer | 2015-08-01 |
| TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma (NCT02529761) | Air Force Military Medical University, China | 2015-08-01 |
| Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma (NCT02526043) | Fudan University | 2015-08-01 |
| Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection (NCT02537158) | Chinese Academy of Medical Sciences | 2015-08-01 |
| Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI (NCT04891874) | Eastern Hepatobiliary Surgery Hospital | 2015-08-01 |
| A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (NCT02435433) | Eli Lilly and Company | 2015-07-20 |
| Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail (NCT02961998) | Sun Yat-sen University | 2015-07-01 |
| In Vitro Models of Liver and Pancreatic Cancer (NCT02436564) | Cambridge University Hospitals NHS Foundation Trust | 2015-07-01 |
| Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1 (NCT02129322) | Zhejiang University | 2015-07-01 |
| Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients (NCT03007225) | Ain Shams University | 2015-07-01 |
| SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist (NCT03950102) | The University of Hong Kong | 2015-07-01 |
| Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry (NCT02558205) | Rush University Medical Center | 2015-07-01 |
| Molecular Basis of Pediatric Liver Cancer (NCT03959800) | University of Pittsburgh | 2015-06-22 |
| Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization (NCT02471313) | National Institutes of Health Clinical Center (CC) | 2015-06-12 |
| REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN) (NCT03292991) | Taipei Veterans General Hospital, Taiwan | 2015-06-09 |
| Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma (NCT02981498) | Sun Yat-sen University | 2015-06-01 |
| Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma (NCT02802124) | Shanghai Proton and Heavy Ion Center | 2015-06-01 |
| Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC (NCT02535117) | Sun Yat-sen University | 2015-06-01 |
| Primary Prevention Hepatocellular Carcinoma by Metformin (NCT02319200) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma (NCT02586285) | Eastern Hepatobiliary Surgery Hospital | 2015-06-01 |
| Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma (NCT04553458) | Sohag University | 2015-06-01 |
| Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC (NCT03806218) | Seoul National University Hospital | 2015-05-16 |
| HR Combined With FOLFOX4 for HCC With PVTT (NCT02452853) | Sun Yat-sen University | 2015-05-01 |
| Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot Study (NCT02446925) | Wright State University | 2015-05-01 |
| TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma (NCT02435953) | Ming Zhao | 2015-05-01 |